Removal of pathogenic bacteria. Chemistry 18, 6485492 (2012). 89. J. Wehling, R. Dringen, R. N.

Removal of pathogenic bacteria. Chemistry 18, 6485492 (2012). 89. J. Wehling, R. Dringen, R. N. Zare, M. Maas, K. Rezwan, Bactericidal activity of partially oxidized nanodiamonds. ACS Nano 8, 6475483 (2014). 90. V. Paget, J. A. Sergent, R. Grall, S. Altmeyer-Morel, PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/21310658 H. A. Girard, T. Petit, C. Gesset, M. Mermoux, P. Bergonzo, J. C. Arnault, S. Chevillard, Carboxylated nanodiamonds are neither cytotoxic nor genotoxic on liver, kidney, intestine and lung human cell lines. Nanotoxicology eight, 466 (2014). 91. Y. A. Huang, C. W. Kao, K. K. Liu, H. S. Huang, M. H. Chiang, C. R. Soo, H. C. Chang, T. W. Chiu, J. I. Chao, E. Hwang, The effect of fluorescent nanodiamonds on neuronal survival and morphogenesis. Sci. Rep. four, 6919 (2014). 92. S. Rojas, J. D. Gispert, R. Martin, S. Abad, C. Menchon, D. Pareto, V. M. Victor, M. Alvaro, H. Garcia, J. R. Herance, Biodistribution of amino-functionalized diamond nanoparticles. In vivo studies primarily based on 18F radionuclide emission. ACS Nano five, 5552559 (2011). 93. K. Yang, H. Gong, X. Shi, J. Wan, Y. Zhang, Z. Liu, In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice immediately after oral and intraperitoneal administration. Biomaterials 34, 2787795 (2013). 94. Q. Wei, L. Zhan, B. Juanjuan, W. Jing, W. Jianjun, S. Taoli, G. Yi’an, W. Wangsuo, Biodistribution of co-exposure to multi-walled carbon nanotubes and nanodiamonds in mice. Nanoscale Res. Lett. 7, 473 (2012). 95. R. Singh, D. Pantarotto, L. Lacerda, G. Pastorin, C. Klumpp, M. Prato, A. Bianco, K. Kostarelos, Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. U.S.A. 103, 3357362 (2006). 96. C. A. Poland, R. Duffin, I. Kinloch, A. Maynard, W. A. Wallace, A. Seaton, V. Stone, S. Brown, W. Macnee, K. Donaldson, Carbon nanotubes introduced in to the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. three, 42328 (2008). 97. S. Kumari, M. K. Singh, S. K. Singh, J. J. A. Gr io, D. Dash, Nanodiamonds activate blood platelets and induce thromboembolism. Nanomedicine 9, 42740 (2013). 98. Y. Xing, W. Xiong, L. Zhu, E. Osawa, S. Hussin, L. Dai, DNA damage in embryonic stem cells caused by nanodiamonds. ACS Nano 5, 2376384 (2011). 99. L. Moore, V. Grobarova, H. Shen, H. B. Man, J. Micova, M. Ledvina, J. Stursa, M. Nesladek, A. Fiserova, D. Ho, Complete interrogation with the cellular response to fluorescent, detonation and functionalized nanodiamonds. Nanoscale 6, 117121721 (2014). 100. X. Y. Zhang, W. B. Hu, J. Li, L. Tao, Y. Wei, A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond. Tox. Res. 1, 628 (2012). 101. J. Lan, N. Gou, C. Gao, M. He, A. Z. Gu, Comparative and mechanistic genotoxicity assessment of nanomaterials via a quantitative toxicogenomics method across various species. Environ. Sci. Technol. 48, 129372945 (2014). 102. M. S. Buckley, R. L. Staib, L. M. Wicks, Mixture therapy in the management of pulmonary arterial hypertension. Int. J. Clin. Pract. Suppl. 179, 133 (2013). 103. R. Smith, T. McCready, S. Yusuf, Combination therapy to stop cardiovascular disease: Slow progress. JAMA 309, 1595596 (2013). 104. G. Derosa, S. Sibilla, Optimizing combination therapy within the management of type two diabetes. Vasc. Overall health Threat Manag. 3, 66571 (2007). 105. J. Dale, N. Alcorn, H. Capell, R. Madhok, Mixture therapy for 3,5,7-Trihydroxyflavone web rheumatoid arthritis: Methot.